Stock listing
TWSE:6550 Polaris Group (北極星藥業-KY) 股價
Follow Polaris Group into a list and get an email when it puts out news.
Share price · TWSE:6550
$10.85 TWD -2.00 (-15.6%)
Close on Nov 20, 2026
- Day range
- $10.85 – $11.85 TWDNov 20, 2026
- Volume
- 834,010 sharesNov 20, 2026
- Market cap
- $5.04B TWDAt the close on Nov 20, 2026 · price × 464.8M shares outstanding
- 52-week range
- $10.85 – $69.20 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $7.90M TWDMedian day 411,950 shares · 7 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:6550 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.85 | -2.00 | -15.6% | $11.85 | $11.85 | $10.85 | 834,010 | |
| $12.85 | -0.20 | -1.5% | $13.20 | $13.35 | $12.70 | 368,788 | |
| $13.05 | -0.10 | -0.8% | $13.10 | $13.60 | $12.90 | 468,375 | |
| $13.15 | -0.60 | -4.4% | $13.50 | $13.80 | $13.15 | 337,982 | |
| $13.75 | +0.25 | +1.9% | $13.40 | $13.80 | $13.40 | 504,887 | |
| $13.50 | -0.25 | -1.8% | $13.70 | $13.80 | $13.40 | 288,052 | |
| $13.75 | -0.35 | -2.5% | $14.20 | $14.20 | $13.60 | 272,155 | |
| $14.10 | +0.15 | +1.1% | $14.20 | $14.40 | $13.80 | 482,923 | |
| $13.95 | +0.25 | +1.8% | $13.80 | $15.00 | $13.80 | 636,107 | |
| $13.70 | -0.60 | -4.2% | $13.10 | $13.95 | $13.10 | 618,385 | |
| $14.30 | -0.50 | -3.4% | $14.70 | $15.00 | $14.30 | 418,772 | |
| $14.80 | 0.00 | 0.0% | $14.90 | $14.90 | $14.30 | 357,888 | |
| $14.80 | -0.25 | -1.7% | $14.90 | $15.05 | $14.60 | 511,332 | |
| $15.05 | +0.30 | +2.0% | $14.60 | $15.25 | $14.60 | 276,755 | |
| $14.75 | -0.45 | -3.0% | $15.45 | $15.45 | $14.65 | 396,948 | |
| $15.20 | 0.00 | 0.0% | $15.20 | $15.25 | $15.15 | 125,409 | |
| $15.20 | -0.05 | -0.3% | $15.35 | $15.45 | $15.20 | 186,826 | |
| $15.25 | -0.20 | -1.3% | $15.45 | $15.45 | $15.25 | 196,101 | |
| $15.45 | 0.00 | 0.0% | $15.45 | $15.45 | $15.45 | 0 | |
| $15.45 | -0.25 | -1.6% | $15.90 | $15.90 | $15.45 | 242,718 | |
| $15.70 | +0.20 | +1.3% | $15.65 | $15.90 | $15.55 | 223,136 | |
| $15.50 | -0.05 | -0.3% | $15.35 | $15.55 | $15.30 | 405,128 | |
| $15.55 | -0.55 | -3.4% | $16.15 | $16.15 | $15.50 | 351,637 | |
| $16.10 | +0.20 | +1.3% | $15.95 | $16.30 | $15.95 | 239,284 | |
| $15.90 | -0.20 | -1.2% | $16.10 | $16.30 | $15.80 | 448,830 | |
| $16.10 | +0.20 | +1.3% | $16.05 | $16.30 | $16.05 | 333,233 | |
| $15.90 | -0.45 | -2.8% | $16.35 | $16.40 | $15.75 | 500,237 | |
| $16.35 | -0.35 | -2.1% | $16.90 | $16.95 | $16.35 | 436,206 | |
| $16.70 | +0.65 | +4.0% | $16.15 | $16.90 | $16.15 | 750,436 | |
| $16.05 | 0.00 | 0.0% | $16.10 | $16.60 | $16.00 | 542,662 | |
| $16.05 | -0.15 | -0.9% | $16.20 | $16.45 | $16.05 | 432,776 | |
| $16.20 | -0.55 | -3.3% | $16.75 | $16.80 | $16.20 | 900,248 | |
| $16.75 | -0.75 | -4.3% | $17.50 | $17.50 | $16.75 | 1,169,236 | |
| $17.50 | -0.35 | -2.0% | $17.80 | $17.80 | $17.40 | 489,604 | |
| $17.85 | +0.45 | +2.6% | $17.25 | $17.95 | $16.90 | 1,532,271 | |
| $17.40 | -1.695 | -8.9% | $18.25 | $18.35 | $17.20 | 1,514,855 | |
| $19.10 | 0.00 | 0.0% | $19.10 | $19.10 | $19.10 | 0 | |
| $19.10 | 0.00 | 0.0% | $19.10 | $19.10 | $19.10 | 0 | |
| $19.10 | 0.00 | 0.0% | $19.10 | $19.10 | $19.10 | 0 | |
| $19.10 | 0.00 | 0.0% | $19.10 | $19.10 | $19.10 | 0 | |
| $19.10 | 0.00 | 0.0% | $19.10 | $19.10 | $19.10 | 0 | |
| $19.10 | 0.00 | 0.0% | $19.10 | $19.10 | $19.10 | 0 | |
| $19.10 | +0.038 | +0.2% | $19.25 | $19.35 | $19.08 | 536,281 | |
| $19.06 | 0.00 | 0.0% | $19.06 | $19.44 | $19.06 | 530,289 | |
| $19.06 | -0.135 | -0.7% | $19.23 | $19.23 | $19.02 | 954,392 | |
| $19.19 | -0.443 | -2.3% | $19.54 | $19.54 | $19.19 | 599,281 | |
| $19.63 | -0.096 | -0.5% | $19.83 | $19.83 | $19.35 | 187,058 | |
| $19.73 | +0.192 | +1.0% | $19.25 | $19.83 | $19.23 | 722,557 | |
| $19.54 | -0.289 | -1.5% | $19.73 | $19.92 | $19.23 | 544,372 | |
| $19.83 | -0.096 | -0.5% | $20.12 | $20.12 | $19.63 | 216,202 | |
| $19.92 | +0.096 | +0.5% | $19.83 | $20.02 | $19.63 | 221,060 | |
| $19.83 | -0.577 | -2.8% | $20.60 | $20.60 | $19.83 | 269,860 | |
| $20.40 | -0.192 | -0.9% | $20.21 | $20.60 | $20.21 | 146,923 | |
| $20.60 | 0.00 | 0.0% | $20.40 | $20.79 | $19.83 | 402,362 | |
| $20.60 | -0.962 | -4.5% | $21.56 | $21.66 | $20.21 | 583,620 | |
| $21.56 | -0.289 | -1.3% | $22.14 | $22.33 | $21.56 | 309,311 | |
| $21.85 | -0.385 | -1.7% | $22.71 | $23.68 | $21.75 | 543,053 | |
| $22.23 | +1.059 | +5.0% | $21.37 | $22.71 | $21.37 | 552,867 | |
| $21.17 | -1.155 | -5.2% | $22.04 | $22.14 | $21.08 | 536,865 | |
| $22.33 | -1.251 | -5.3% | $24.93 | $25.02 | $21.94 | 1,627,118 | |
| $23.58 | +2.117 | +9.9% | $23.58 | $23.58 | $23.10 | 380,959 | |
| $21.46 | +1.925 | +9.9% | $19.83 | $21.46 | $19.83 | 530,380 |
Splits
1 split · TWSE:6550 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 40-for-77 | Consolidation |
- Ticker
- TWSE:6550
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TWSE
- Currency
- TWD
What changed lately
Latest news release · Sep 28, 2026
Lombard backs Polaris Autoliners fleet expansion with 33.2 million refinancing deal
Latest news
Lombard backs Polaris Autoliners fleet expansion with 33.2 million refinancing deal
Sep 28, 2026
Closed $17.40 (-8.9%) on Sep 29, 2026
Polaris Group on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in the last 12 months · 10 in all · newest Sep 28, 2026 · oldest 2022
- Decks
- 1 deck · latest May 4, 2022
Valuation
EV/sales 75.1× against a median of 88.1×: 5th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $5.10B TWD
- P/E
- Loss
- EV/sales
- 75.1×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.1×
- Gross margin
- −618.2%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.5×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Polaris Group · TWSE:6550 | US$153.0M | US$154.8M | n/a | 75.1× | n/a | 1.1× | n/a | 0.5× | n/a |
| ImmuneOncia Therapeutics Inc. · KRX:424870 | US$159.0M | US$89.79M | n/a | n/a | n/a | 2.1× | n/a | 0.0× | n/a |
| Jiangsu Recbio Technology Co., Ltd. Class H · HKEX:2179 | US$157.3M | US$230.2M | n/a | 124× | n/a | 2.1× | n/a | 1.4× | n/a |
| BioVersys AG · SIX:BIOV | US$154.1M | US$97.45M | n/a | 102× | n/a | 2.9× | n/a | 0.5× | n/a |
| InflaRx N.V. · NASDAQ:IFRX | US$153.3M | US$135.7M | n/a | 4,215× | n/a | 19.5× | n/a | 0.0× | 1.61 |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H · HKEX:1541 | US$152.0M | US$64.40M | n/a | 2.9× | n/a | 1.6× | −141.7% | 0.6× | n/a |
| Saniona AB · OMXSTO:SANION | US$151.6M | US$104.0M | 8.4× | 2.5× | 5.2× | 2.8× | 43.2% | 0.0× | n/a |
| Palisade Bio, Inc. · NASDAQ:PALI | US$150.6M | US$36.96M | n/a | 73.9× | n/a | 1.3× | n/a | 0.0× | 1.41 |
| Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN | US$150.3M | US$80.67M | n/a | n/a | n/a | 4.9× | n/a | 0.0× | 1.95 |
| Veraxa Biotech AG · NASDAQ:VRXA | US$147.1M | US$145.1M | n/a | 5,202× | n/a | n/a | n/a | n/a | 1.11 |
| ProQR Therapeutics N.V. · NASDAQ:PRQR | US$146.8M | US$49.73M | n/a | 2.2× | n/a | 2.0× | −210.7% | 0.2× | 1.73 |
| Median of the others | US$151.8M | US$93.62M | 8.4× | 88.1× | 5.2× | 2.1× | −141.7% | 0.0× | 1.61 |
Team and board
Officers
| Officer | Role |
|---|---|
| Samuel Chen | Chairman & Chief Executive Officer |
| Amanda Johnston | Senior Vice President, Clinical Affairs |
| Chris Huxsoll | Senior Vice President, Operations |
| John Bomalaski | Executive Vice President, Medical Affairs |
Board
| Director | Role |
|---|---|
| Samuel Chen | Chairman & Chief Executive Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | May 11, 2023 · After close | +1.2% |
| Q4 2022 | Mar 16, 2023 · After close | +2.8% |
| Q3 2022 | Nov 13, 2022 · After close | −2.5% |
| Q2 2022 | Aug 21, 2022 · After close | +3.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| IPO Roadshow (May 2022) | IPO roadshow | 34 slides | May 4, 2022 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.6M | 107.0M | 7.48M | 6.44M | 15.0M | 9.41M | ||||
| Cost of revenue | 310.9M | 183.9M | 145.4M | 148.3M | 165.7M | 140.2M | 138.3M | 110.5M | 113.8M | 128.1M |
| Gross profit | -270.3M | -76.9M | -137.9M | -141.9M | -150.6M | -130.8M | -138.3M | -110.5M | -113.8M | -128.1M |
| Research and development | 2.16B | 2.19B | 1.54B | 924.0M | 554.3M | 545.2M | 633.1M | 785.9M | 615.9M | 697.8M |
| Selling, general and administrative | 346.1M | 330.5M | 307.3M | 235.0M | 179.7M | 135.3M | 162.1M | |||
| Operating income | -2.88B | -2.63B | -1.85B | -1.16B | -731.9M | -678.0M | -795.2M | -1.01B | -843.7M | -948.2M |
| Depreciation and amortization | 376.4M | 315.1M | 135.4M | 143.7M | 154.1M | 133.3M | 138.3M | 110.5M | 113.8M | 128.1M |
| EBITDA | -2.50B | -2.32B | -1.71B | -1.01B | -577.8M | -544.7M | -656.9M | -903.2M | -729.9M | -820.0M |
| Interest expense | 99.4M | 57.1M | 32.6M | 11.1M | 14.7M | 5.16M | 35.5M | 44.9M | 55.6M | 50.3M |
| Income before tax | -3.94B | -2.55B | -1.56B | -1.14B | -730.5M | -654.5M | -828.9M | -1.03B | -897.4M | -980.3M |
| Income tax | 390.0K | 5.21M | 15.6M | 5.53M | 777.0K | 48.0K | 820.0K | 47.0K | 1.08M | 2.16M |
| Net income | -3.95B | -2.50B | -1.58B | -1.15B | -740.5M | -660.2M | -829.8M | -1.03B | -898.5M | -982.5M |
| Earnings per share, basic | -9.87 | -6.45 | -4.09 | -3.03 | -2.10 | -1.95 | -4.75 | -6.89 | -6.94 | -7.98 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.83B | 1.95B | 3.62B | 7.23B | 5.88B | 152.2M | 2.61B | 394.9M | 706.8M | 357.8M |
| Short-term investments | 913.0M | 1.18B | 1.33B | 156.0M | 446.3M | 1.70B | 9.87M | |||
| Receivables | 34.9M | 24.5M | 25.1M | 521.0K | 5.35M | 8.15M | 312.0K | 14.0K | 2.00K | 36.0K |
| Inventory | 121.9M | 67.4M | 36.4M | 0 | ||||||
| Current assets | 3.02B | 3.33B | 5.11B | 7.54B | 6.35B | 1.88B | 2.64B | 428.0M | 731.3M | 373.9M |
| Goodwill | 755.4M | 2.07B | ||||||||
| Total assets | 8.17B | 9.09B | 9.10B | 9.22B | 7.82B | 3.36B | 4.11B | 1.98B | 2.22B | 1.97B |
| Accounts payable | 9.12M | 2.33M | 2.14M | 521.0K | ||||||
| Current liabilities | 585.9M | 468.9M | 959.4M | 250.8M | 436.8M | 278.0M | 236.1M | 1.09B | 465.9M | 1.01B |
| Long-term debt | 2.09B | 1.62B | 353.0M | 30.8M | 117.3M | 126.2M | 202.3M | |||
| Total debt | 2.35B | 1.88B | 1.20B | 382.6M | 436.8M | 325.6M | 276.1M | 1.03B | 1.01B | 1.52B |
| Total liabilities | 2.87B | 2.32B | 1.46B | 545.2M | 608.2M | 480.9M | 496.6M | 1.34B | 1.22B | 1.73B |
| Shareholders' equity | 5.30B | 6.70B | 7.37B | 8.67B | 7.21B | 2.88B | 3.61B | 640.5M | 1.00B | 207.3M |
| Shares outstanding | 399.6M | 388.2M | 386.0M | 380.2M | 353.0M | 338.9M | 174.8M | 149.8M | 129.4M | 123.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2.39B | -2.03B | -1.26B | -1.03B | -539.3M | -585.7M | -747.8M | -778.7M | -708.1M | -782.5M |
| Capital spending | -795.3M | -1.66B | -333.2M | -69.6M | -204.3M | -51.7M | -50.2M | -43.2M | -20.7M | -305.1M |
| Free cash flow | -3.19B | -3.69B | -1.59B | -1.10B | -743.6M | -637.4M | -798.0M | -821.9M | -728.8M | -1.09B |
| Cash from investing | -659.7M | -1.63B | -3.24B | 199.7M | 1.02B | -1.79B | -42.5M | -58.7M | -19.2M | -268.5M |
| Cash from financing | 2.96B | 1.85B | 919.2M | 1.48B | 5.35B | 1.18M | 3.08B | 642.9M | 1.19B | 450.1M |
| Change in cash | -115.8M | -1.67B | -3.61B | 1.35B | 5.73B | -2.46B | 2.21B | -311.9M | 349.0M | -600.9M |
Cap table
Built by 6ix from Polaris Group’s releases
- Common shares
- 464,846,344
- Fully diluted
- 464,846,344
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 464,846,344 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 464,846,344 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Amanda Johnston | Senior Vice President, Clinical Affairs · Since at least Nov 5, 2026 |
| Chris Huxsoll | Senior Vice President, Operations · Since at least Nov 5, 2026 |
| John Bomalaski | Executive Vice President, Medical Affairs · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Polaris Group.